This page shows Mymetics (MYMX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 2 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Mymetics passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass.
For every $1 of reported earnings, Mymetics generates $0.36 in operating cash flow (-$1.7M OCF vs -$4.7M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Key Financial Metrics
Mymetics generated -$1.7M in free cash flow in fiscal year 2021, representing cash available after capex. This represents an increase of 0.1% from the prior year.
Mymetics reported -$4.7M in net income in fiscal year 2021. This represents a decrease of 13.8% from the prior year.
Mymetics held $571K in cash against $162K in long-term debt as of fiscal year 2021.
Mymetics had 304M shares outstanding in fiscal year 2021. This represents an increase of 0.0% from the prior year.
Mymetics invested $10K in capex in fiscal year 2021, funding long-term assets and infrastructure. This represents a decrease of 28.6% from the prior year.
MYMX Income Statement
| Metric | Q1'22 | Q1'21 | Q2'21 | Q1'21 | Q4'20 | Q2'20 | Q2'20 |
|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | $308K | N/A | N/A | $252K | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | $684K | N/A | N/A | $676K | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | -$1K | N/A | N/A | -$1K | N/A | -$1.0M+11.4% | -$1.2M |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MYMX Balance Sheet
| Metric | Q1'22 | Q1'21 | Q2'21 | Q1'21 | Q4'20 | Q2'20 | Q2'20 |
|---|---|---|---|---|---|---|---|
| Total Assets | $7.5M-1.2% | $7.6M | N/A | N/A | $8.1M | N/A | N/A |
| Current Assets | $610K-9.4% | $673K | N/A | N/A | $1.2M | N/A | N/A |
| Cash & Equivalents | $122K-78.6% | $571K+113.1% | $268K-63.7% | $738K-31.9% | $1.1M-4.6% | $1.1M | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | $411K+2640.0% | $15K-73.2% | $56K | N/A | $71K | N/A | N/A |
| Goodwill | $6.7M0.0% | $6.7M0.0% | $6.7M | N/A | $6.7M | N/A | N/A |
| Total Liabilities | $7.6M-1.2% | $7.7M | N/A | N/A | $8.2M | N/A | N/A |
| Current Liabilities | $68.6M+1.7% | $67.4M | N/A | N/A | $63.3M | N/A | N/A |
| Long-Term Debt | $164K+1.2% | $162K | N/A | N/A | $156K | N/A | N/A |
| Total Equity | -$61K-2.0% | -$60K+99.9% | -$57.7M-101845.0% | -$57K-2.3% | -$55K+99.9% | -$53.4M-2.0% | -$52.4M |
| Retained Earnings | -$99.0M-1.2% | -$97.8M-2.5% | -$95.4M | N/A | -$93.0M | N/A | N/A |
MYMX Cash Flow Statement
| Metric | Q1'22 | Q1'21 | Q2'21 | Q1'21 | Q4'20 | Q2'20 | Q2'20 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$454K | N/A | -$470K-43.7% | -$327K | N/A | N/A | N/A |
| Capital Expenditures | $2K | N/A | $0-100.0% | $10K | N/A | N/A | N/A |
| Free Cash Flow | -$456K | N/A | -$470K-39.5% | -$337K | N/A | N/A | N/A |
| Investing Cash Flow | -$2K | N/A | $0+100.0% | -$10K | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
MYMX Financial Ratios
| Metric | Q1'22 | Q1'21 | Q2'21 | Q1'21 | Q4'20 | Q2'20 | Q2'20 |
|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | -0.0% | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 0.010.0 | 0.01 | N/A | N/A | 0.02 | N/A | N/A |
| Debt-to-Equity | -2.68+0.0 | -2.70 | N/A | N/A | -2.82 | N/A | N/A |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$60K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Mymetics profitable?
No, Mymetics (MYMX) reported a net income of -$4.7M in fiscal year 2021.
How much debt does Mymetics have?
As of fiscal year 2021, Mymetics (MYMX) had $571K in cash and equivalents against $162K in long-term debt.
What is Mymetics's free cash flow?
Mymetics (MYMX) generated -$1.7M in free cash flow during fiscal year 2021. This represents a 0.1% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Mymetics's operating cash flow?
Mymetics (MYMX) generated -$1.7M in operating cash flow during fiscal year 2021, representing cash generated from core business activities.
What are Mymetics's total assets?
Mymetics (MYMX) had $7.6M in total assets as of fiscal year 2021, including both current and long-term assets.
What are Mymetics's capital expenditures?
Mymetics (MYMX) invested $10K in capital expenditures during fiscal year 2021, funding long-term assets and infrastructure.
How many shares does Mymetics have outstanding?
Mymetics (MYMX) had 304M shares outstanding as of fiscal year 2021.
What is Mymetics's current ratio?
Mymetics (MYMX) had a current ratio of 0.01 as of fiscal year 2021, which is below 1.0, which may suggest potential liquidity concerns.
What is Mymetics's debt-to-equity ratio?
Mymetics (MYMX) had a debt-to-equity ratio of -2.70 as of fiscal year 2021, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Mymetics's return on assets (ROA)?
Mymetics (MYMX) had a return on assets of -62.0% for fiscal year 2021, measuring how efficiently the company uses its assets to generate profit.
What is Mymetics's cash runway?
Based on fiscal year 2021 data, Mymetics (MYMX) had $571K in cash against an annual operating cash burn of $1.7M. This gives an estimated cash runway of approximately 4 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Mymetics's debt-to-equity ratio negative or unusual?
Mymetics (MYMX) has negative shareholder equity of -$60K as of fiscal year 2021, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Mymetics's Piotroski F-Score?
Mymetics (MYMX) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Mymetics's earnings high quality?
Mymetics (MYMX) has an earnings quality ratio of 0.36x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.